Emerging Strategies in Multi-Cancer Early Detection
September 28th 2023A panel of experts discusses the current landscape of multi-cancer early detection, addressing its potential to broaden access and improve cancer screening, emphasizing the importance of clinical trials and equitable healthcare distribution.
My Treatment Approach: Interpreting the Data for Early-Stage HR+ Breast Cancer
June 29th 2023In this series, we will discuss recent advances in the treatment of HR+ breast cancer. We will review two patient cases and discuss our treatment approach to illustrate how we are incorporating recent trial data into our clinical practice.
Recent Updates in Fertility Preservation for Premenopausal Patients with Breast Cancer
June 21st 2023Expert oncologists Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, review recent clinical data and discuss the current state of fertility preservation in premenopausal patients with breast cancer.
Treatments for Advanced or Recurrent Endometrial Cancer: Beyond Chemotherapy
June 20th 2023Experts discuss the evolving treatment landscape in advanced or recurrent endometrial cancer. They review the latest updates in clinical research, highlighting non-chemotherapy approaches and their impact on treatment selection.
Optimizing Outcomes in Patients With RCC: Translating Evidence to Clinical Practice
May 22nd 2023Expert panelists from the UT Southwestern Medical Center review real world patient cases of renal cell carcinoma to illustrate recent clinical data and exhibit how it has been applied at their institution.
My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer
April 17th 2023Andrew Armstrong, MD, and Matthew Manning, MD, review the profiles of three patients with metastatic castration-resistant prostate cancer (mCRPC) and discuss how they would have approached their treatment, given recent advances in radiotherapy and other options in the field.